Inspire Medical Systems, Inc. (INSP)
USD 186.97
(-1.96%)
USD 186.97
(-1.96%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 104.29 Million USD | 51.44% |
| 2022 | 68.86 Million USD | 4.29% |
| 2021 | 66.03 Million USD | 28.37% |
| 2020 | 51.44 Million USD | 24.2% |
| 2019 | 41.41 Million USD | 14.79% |
| 2018 | 36.08 Million USD | 52.84% |
| 2017 | 23.6 Million USD | 19.69% |
| 2016 | 19.72 Million USD | 0.0% |
| 2015 | - USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 96.81 Million USD | -7.17% |
| 2024 Q2 | 90.31 Million USD | -6.71% |
| 2024 Q3 | 99.63 Million USD | 10.31% |
| 2023 FY | 104.29 Million USD | 51.44% |
| 2023 Q3 | 95.31 Million USD | 7.23% |
| 2023 Q2 | 88.88 Million USD | 32.27% |
| 2023 Q1 | 67.19 Million USD | -2.42% |
| 2023 Q4 | 104.29 Million USD | 9.42% |
| 2022 Q1 | 64.66 Million USD | -2.08% |
| 2022 Q4 | 68.86 Million USD | 20.15% |
| 2022 FY | 68.86 Million USD | 4.29% |
| 2022 Q3 | 57.31 Million USD | -11.84% |
| 2022 Q2 | 65.01 Million USD | 0.55% |
| 2021 Q1 | 50.28 Million USD | -2.25% |
| 2021 FY | 66.03 Million USD | 28.37% |
| 2021 Q4 | 66.03 Million USD | 12.7% |
| 2021 Q3 | 58.59 Million USD | 12.05% |
| 2021 Q2 | 52.29 Million USD | 4.0% |
| 2020 Q4 | 51.44 Million USD | 19.74% |
| 2020 Q1 | 38.33 Million USD | -7.45% |
| 2020 FY | 51.44 Million USD | 24.2% |
| 2020 Q2 | 37.71 Million USD | -1.61% |
| 2020 Q3 | 42.96 Million USD | 13.91% |
| 2019 Q1 | 32.19 Million USD | -10.78% |
| 2019 FY | 41.41 Million USD | 14.79% |
| 2019 Q4 | 41.41 Million USD | 11.43% |
| 2019 Q3 | 37.17 Million USD | 12.38% |
| 2019 Q2 | 33.07 Million USD | 2.75% |
| 2018 Q3 | 32.4 Million USD | 3.48% |
| 2018 FY | 36.08 Million USD | 52.84% |
| 2018 Q2 | 31.31 Million USD | -4.48% |
| 2018 Q1 | 32.78 Million USD | 38.89% |
| 2018 Q4 | 36.08 Million USD | 11.33% |
| 2017 Q1 | - USD | 0.0% |
| 2017 Q4 | 23.6 Million USD | 0.0% |
| 2017 FY | 23.6 Million USD | 19.69% |
| 2016 FY | 19.72 Million USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Abbott Laboratories | 34.38 Billion USD | 99.697% |
| Allurion Technologies Inc. | 142.19 Million USD | 26.654% |
| Artivion, Inc. | 510.61 Million USD | 79.574% |
| Avanos Medical, Inc. | 456.1 Million USD | 77.133% |
| Butterfly Network, Inc. | 84.22 Million USD | -23.837% |
| Butterfly Network, Inc. | 84.22 Million USD | -23.837% |
| Bio-Rad Laboratories, Inc. | 3.55 Billion USD | 97.069% |
| Boston Scientific Corporation | 15.6 Billion USD | 99.332% |
| Perspective Therapeutics, Inc. | 3.44 Million USD | -2923.978% |
| CONMED Corporation | 1.46 Billion USD | 92.885% |
| Edwards Lifesciences Corporation | 2.64 Billion USD | 96.055% |
| Paragon 28, Inc. | 162.95 Million USD | 35.998% |
| Glaukos Corporation | 478.64 Million USD | 78.21% |
| Globus Medical, Inc. | 1.08 Billion USD | 90.415% |
| Integer Holdings Corporation | 1.41 Billion USD | 92.62% |
| Medtronic plc | 39.56 Billion USD | 99.736% |
| Nevro Corp. | 330.31 Million USD | 68.425% |
| Owlet, Inc. | 73.79 Million USD | -41.326% |
| Penumbra, Inc. | 377.36 Million USD | 72.361% |
| Vicarious Surgical Inc. | 21.89 Million USD | -376.351% |
| Smith & Nephew plc | 4.77 Billion USD | 97.813% |
| Sonendo, Inc. | 49.74 Million USD | -109.68% |
| STERIS plc | 4.74 Billion USD | 97.804% |
| Stryker Corporation | 21.31 Billion USD | 99.511% |
| Vapotherm, Inc. | 132.95 Million USD | 21.552% |
| Zimmer Biomet Holdings, Inc. | 9 Billion USD | 98.842% |